Imatero-400: Side Effects & Dosing

This brand may be off-market.

Imatero-400

Basic Prescribing Info

Contents

Imatinib mesylate

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA01 - imatinib ; Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Already a member? Sign In